Anandhi R Johri

Suggest Changes
Learn More
PURPOSE To evaluate the safety, maximum tolerated dose (MTD), and pharmacokinetics of patupilone administered once every 3 weeks with proactive standardized diarrhea management in patients with(More)
AIMS The objective of this article is to report our findings regarding large-volume fat transfer in patients who have undergone autologous breast reconstruction with the latissimus dorsi (LD) flap(More)
3593 Background: In previous clinical studies, a positive effect was noted in patients with CRC heavily pretreated with chemotherapy who received the novel microtubule stabilizer patupilone (EPO906;(More)
  • 1